Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sen. Cornyn Plans Bill To Secure US Genomic Research From Foreign 'Interference, Espionage And Exfiltration'

Executive Summary

Threats from Chinese and other foreign researchers stealing US medical research and genomic intellectual property for their home countries’ gain continue, and in response, one Texas senator plans to introduce a Secure Our Research Act to protect federally funded research from foreign theft.

You may also be interested in...



US Election 2020: Industry Loses Three Favored Incumbents In Battle For Senate Control

A few of the US Senate candidates favored and given tens of thousands of dollars by industry have lost their battles for re-election.

US Senators Ask HHS IG To Investigate CMS Genetic Test Payments To Chinese Firms

Two Republican senators this week asked the HHS Office of Inspector General (OIG) to look into suspected CMS payments and trading of US citizens’ genomic information with US-partnered Chinese laboratory companies.

MD Anderson Cancer Center Kicks Out Chinese Researchers Following NIH Grant Inquiries

Investigations into violations of National Institutes of Health grant-funding rules targeting scientists from China and other countries working on genomic research have already resulted in three firings at a famous cancer center in Houston.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125225

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel